Patents by Inventor Jiang Tian LIU

Jiang Tian LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thienoisoquinolines and their derivatives for the treatment of cancer
    Patent number: 11034702
    Abstract: The present disclosure relates to fused N-arylsulfonamidyl-thienoisoquinoline compounds, derivatives and pharmaceutical compositions thereof, and methods and uses in inhibiting cancer cell growth, along with a supplemental anti-cancer agent. Centrosome targeting and microtubule depolymerisation are attractive in designing the present chemotherapeutic compounds. The various diseases and conditions treated include various types of cell cancers, and in vitro inhibition.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: June 15, 2021
    Assignee: VALORBEC, SOCIÉTÉ EN COMMANDITE
    Inventors: Pasquale Forgione, Alisa Julienne Piekny, Dilan Boodhai Jaunky, Fei Chen, Jiang Tian Liu
  • THIENOISOQUINOLINES AND THEIR DERIVATIVES FOR TARGETING TUBULIN, CH-TOG, AURORA A KINASE, TPX2, CDK5RAP2 AND/OR ASPM
    Publication number: 20200276181
    Abstract: The present disclosure relates to compounds, methods and uses thereof for targeting tubulin, ch-TOG, Aurora A kinase, TPX2, Cdk5rap2 and/or ASPM and for the treatment of cancer in a subject. For example, the compounds can comprise compounds of Formula I or a pharmaceutically acceptable salt, solvate or prodrug thereof. A, Z, RA, RB, R1, R2, R3, R4 and R5 can have different values.
    Type: Application
    Filed: November 15, 2018
    Publication date: September 3, 2020
    Applicant: VALORBEC, SEC
    Inventors: Pasquale FORGIONE, Alisa Julienne PIEKNY, Kevin LAROCQUE, Dilan Boodhai JAUNKY, Fei CHEN, Jiang Tian LIU
  • THIENOISOQUINOLINES AND THEIR DERIVATIVES FOR THE TREATMENT OF CANCER
    Publication number: 20200024284
    Abstract: The present disclosure relates to fused N-arylsulfonamidyl-thienoisoquinoline compounds, derivatives and pharmaceutical compositions thereof, and methods and uses in inhibiting cancer cell growth, along with a supplemental anti-cancer agent. Centrosome targeting and microtubule depolymerisation are attractive in designing the present chemotherapeutic compounds. The various diseases and conditions treated include various types of cell cancers, and in vitro inhibition.
    Type: Application
    Filed: December 6, 2017
    Publication date: January 23, 2020
    Inventors: Pasquale FORGIONE, Alisa Julienne PIEKNY, Dilan Boodhai JAUNKY, Fei CHEN, Jiang Tian LIU